Background: Photon (X-ray) radiotherapy (XRT) kills cells via DNA damage, however, how proton radiotherapy (PRT) causes cell death in head and neck squamous cell carcinoma (HNSCC) is unclear. We investigated mechanisms of HNSCC cell death after XRT versus PRT. Methods: We assessed type of death in 2 human papillomavirus (HPV)-positive and two HPV-negative cell lines: necrosis and apoptosis (Annexin-V fluorescein isothiocyanate [FITC]); senescence (β-galactosidase); and mitotic catastrophe (γ-tubulin and diamidino-phenylindole [DAPI]). Results: The XRT-induced or PRT-induced cellular senescence and mitotic catastrophe in all cell lines studied suggested that PRT caused cell death to a greater extent than XRT. After PRT, mitotic catastrophe peaked in HPV-negative and HPV-positive cells at 48 and 72 hours, respectively. No obvious differences were noted in the extent of cell necrosis or apoptosis after XRT versus PRT. Conclusion: Under the conditions and in the cell lines reported here, mitotic catastrophe and senescence were the major types of cell death induced by XRT and PRT, and PRT may be more effective.
| INTRODUCTION
Photon (X-ray)-based radiotherapy (XRT), alone or in combination with chemotherapy, is the standard of care for locoregionally advanced head and neck squamous cell carcinoma (HNSCC). [1] [2] [3] Although this approach has improved locoregional control, that control comes at the cost of significant short-term and long-term treatment-related complications, which may force treatment interruptions that can affect survival. [4] [5] [6] The need to minimize treatment-related toxicity must be balanced with the need for treatment efficacy to maintain function and quality of life as well as oncologic control among long-term survivors. Advances in radiotherapy technology are being sought in an effort to enhance the precision of radiation delivery to avoid treatment-related toxicity [7] [8] [9] [10] [11] [12] [13] and to allow radiation to be safely combined with molecularly targeted radiation sensitizers or modifiers, all with the ultimate goal of enhancing tumor cell killing and improving tumor control. [14] [15] [16] [17] Strategies to reduce radiation-related toxicity include the use of proton radiotherapy (PRT), a highly precise radiotherapy modality 7, 8 that has shown promise in the treatment of HNSCC. [9] [10] [11] [12] [13] Because proton beams deliver the greatest dose at the distal edge of their range (via the Bragg peak), PRT theoretically allows delivery of tightly conformal doses to tumors with little or no dose to adjacent normal structures, 18 which presumably would confer better tumor control with less treatment-related toxicity than XRT. 9 The mechanisms by which XRT kills cells and ways of interfering with these mechanisms to enhance antitumor responses are being intensely studied. The XRT is known to induce single-strand and double-strand breaks in DNA 19, 20 and to kill cancer cells via apoptosis, necrosis, autophagy, mitotic catastrophe, and senescence. [21] [22] [23] [24] [25] The type of DNA damage induced by PRT is thought to be more complex and to have more severe biological consequences than that caused by XRT. 26, 27 In addition, the mechanisms by which PRT kills cells are unclear. Discovering the type of cancer cell death caused by PRT and the underlying molecular mechanisms may open a new avenue of optimizing tumor control with PRT. Two biologically and clinically distinct types of HNSCC have been identified---one related to tobacco and alcohol consumption and the other associated with the human papillomavirus (HPV). [28] [29] [30] [31] Patients with HPVassociated HNSCC are usually younger individuals who do not smoke tobacco or drink alcohol 1 and their prognosis is generally better than that for individuals with HPVnegative HNSCC. 32 The HPV-positive HNSCC is associated with P53 degradation and P16 upregulation. 33 Both p53 and p16 are important in XRT-induced tumor cell death, 23, 24 however, whether HPV status influences the type of cell death induced by XRT or PRT in HNSCC is unknown. To avoid bias from the potential influence of HPV status on our results, we studied the effects of XRT versus PRT on apoptosis, necrosis, mitotic catastrophe, and senescence in 2 HPV-positive cell lines and 2 HPVnegative cell lines.
| MATERIALS AND METHODS

| Radiation dose measurements and cell irradiation
Clinical 200-MeV proton beams (18 cm × 18 cm field) or 6-MV X-ray beams (25 cm × 25 cm field) were used to deliver radiation. Cells were positioned in the centers of the irradiation fields. Irradiation and dose measurements were done either at 14 cm (for PRT, in the middle of the spread out Bragg peak) or at 10 cm (for XRT) underwaterequivalent depth using water equivalent material. Cells were exposed to a single dose of 4 Gy delivered either with a passive scattering proton therapy beam (PROBEAT Proton Beam Therapy System, Hitachi America, Tarrytown, NY; energy, 200 MeV); or with same dose of 6-MV X-rays (Varian 21EX Linear Accelerator, Varian Medical Systems, Palo Alto, CA). This dose was chosen for its ability to produce reproducible cell-survival curves; for its effectiveness against the HPV-negative cell lines (for which the D0, that is, dose that reduces the surviving fraction to 37%, is between 3 and 4 Gy); and because its biologically effective dose, assuming an alpha/beta ratio of 10 for head and neck cancer, is similar to that of two 2.2-Gy once-daily doses (corresponding biologically effective doses of 5.6 Gy and 5.4 Gy). Absolute doses were calibrated according to TRS-398 34 (for PRT) or TG-51 35 (for XRT) to 1% accuracy. Dose uncertainties arising from cell positioning or beam fluctuation were estimated as being within ±2%.
| Cell cultures
For these studies, we used 4 HNSCC cell lines, as described in our previous publication. 36 The 2 HPV-negative HNSCC cell lines (SqCC/Y1 and HN5) and 2 HPV-positive cell lines (UPCI-SCC-154 and UMSCC-47) were provided by Dr Jeffery Myers. The HPV-negative cell lines were maintained in DMEM/F-12 (Gibco, Thermo Fisher, Grand Island, NY). UMSCC-47 cells were maintained in DMEM (Gibco) supplemented with 2% MEM vitamins (Gibco), 1% sodium pyruvate (Lonza, Houston, TX), and 1% nonessential amino acids (Gibco). UPCI-SCC-154 cells were maintained in MEM (Gibco). All culture media were supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO), 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco). Cells were grown as monolayers in 75-cm 2 flasks and maintained in a humidified 5% CO 2 /95% air atmosphere at 37 C.
The identities of all cell lines were confirmed by genotyping (STR profiling) at MD Anderson's Characterized Cell Line Core Facility (NCI Core Grant CA016672). At least 3 sets of independent experiments were performed.
| Flow cytometry analysis
| Senescence analysis
Cells were plated on coverslips placed in 35-mm culture dishes overnight and irradiated or not irradiated with a single dose of 4 Gy of protons or X-rays. At 4 or 6 days after irradiation, cellular senescence was determined in terms of senescence-associated (SA)-β-galactosidase activity by using the SA-β-Gal Kit (Sigma-Aldrich), in accord with the manufacturer's instructions. Briefly, cells were washed in PBS and fixed for about 5 minutes in 0.25% paraformaldehyde. After extensive washing with PBS, cells were incubated at 37 C in the staining solution without CO 2 for 24 hours. Cells were photographed with an optic microscope (EVOS XL Core Imaging System, Life Technologies, Carlsbad, CA) in at least 10 randomly chosen microscopic fields at ×20 magnification. The SA-β-Gal-positive cells were defined as those with blue cytoplasmic staining and were counted as a percentage of the total number of cells. The results are shown as the average percentages from 3 independent experiments.
| Immunocytochemical analysis
Cells were plated on coverslips placed in 35-mm culture dishes overnight and then irradiated with 
| Statistical analyses
Each experiment was repeated at least 3 times. Data are presented as means ± SEM. Student's t tests (unpaired, unequal variance) were used to compare 2 groups of independent samples for percentages of cells in apoptosis, necrosis, senescence, and mitotic catastrophe. Any P value < .05 was considered to indicate statistical significance.
3 | RESULTS
| Proton-induced and X-ray-induced necrosis and apoptosis
First, to identify the major mechanism of cell death in HNSCC cells exposed to PRT or XRT, we irradiated our HNSCC cell lines with a single 4-Gy dose and measured necrotic and apoptotic cell death at 4 hours, 24 hours, and 48 hours afterward. Two cell lines were HPV-negative (SqCC/Y1 and HN-5) and 2 were HPV-positive (UPCI-SCC-154 and UMSCC-47). Figure 1A and Supporting Figure S1 ). In contrast with necrotic cells, the percentages of apoptotic cells were smaller at all measurement points, ranging from 0.98% (±0.3) to 7.6% (±2.9) for all cell lines tested ( Figure 1B and Supporting Figure S1 ). At 4 hours after a single 4-Gy dose, both XRT and PRT led to slight increases in the percentage of apoptotic cells but only in UMSCC-47 cells (XRT 2.17-fold increase vs control; PRT 1.71-fold increase vs control). At 24 hours after irradiation, slight (nonsignificant) increases were seen in the HPV-negative SqCC/Y1 cells (XRT 1.46-fold increase vs control; PRT 1.34-fold increase vs control) and in the HPV-positive UMSCC-47 cells (XRT 2.76-fold increase vs control; PRT 1.85-fold increase vs control). At 48 hours after irradiation, XRT---but not PRT---led to a significant increase in apoptotic HPV-negative SqCC/Y1 cells (XRT 2.07-fold increase vs control; P = .027). All other cell lines showed nonsignificant changes in percentages of apoptotic cells after XRT or PRT ( Figure 1B and Supporting Figure S1 ).
| Proton-induced and X-ray-induced senescence
Because XRT also can cause senescence, we next investigated whether a 4-Gy dose of XRT or PRT would induce senescence in our 4 HNSCC cell lines by using a wellestablished senescence-associated biomarker (SA-β-gal). 23, 37 The percentages of senescent cells in the control conditions were relatively low, ranging from 2.17% (±0.76) to 3.15% (±0.69) at 4 or 6 days after irradiation, except for the UMSCC-47 cells at 6 days, which was 9.18% (±2.85). The XRT significantly increased the percentages of senescent cells at 4 days and at 6 days after irradiation in all cell lines, ranging from 4.85% (±1.13) to 17.77% (±3.42) (all P ≤ .002; Figure 2) . Notably, PRT produced larger percentages of senescent cells than did XRT in all 4 cell lines and at both measurement times, ranging from 9.48% (±1.23) to 37.00% (±5.04; all P < .001 vs control; and all P ≤ .003 vs XRT; Figure 2 ). In addition, the cell line with the greatest increase in senescent cells after PRT was the HPV-positive UMSCC-47 at 6 days.
| Proton-induced and X-ray-induced mitotic catastrophe
Because mitotic catastrophe is an important mechanism of cell death in solid tumors receiving clinical radiotherapy, we next assessed mitotic catastrophe after a 4-Gy dose of XRT or PRT in our 4 HNSCC cell lines by co-staining the cytoplasm for γ-tubulin (with Texas Red) and the nucleus with DAPI (blue) and noting morphologic changes in the nuclei. 23 Figure 3 ). Moreover, the peak of mitotic catastrophe induced by PRT took place at 48 hours after irradiation in the HPV-negative cells and at 72 hours for the HPV-positive cells studied ( Figure 3E ).
| DISCUSSION
Our key findings from this study indicate that senescence and mitotic catastrophe were the major types of cell death induced by a single 4-Gy fraction of XRT or PRT in all 4 of the HNSCC cell lines tested; that PRT tended to kill more cells by either method than did XRT; and that both PRT and XRT produced high levels of mitotic catastrophe at 48 hours after irradiation in the 2 HPV-negative cell lines and at 72 hours in the 2 HPV-positive cell lines tested. Further, both XRT and PRT led to significant necrosis at 48 hours after irradiation in the HPV-negative SqCC/Y1 cells; and both XRT and PRT slightly increased apoptosis in the HPVpositive UMSCC-47 and HPV-negative SqCC/Y1 cells, with slightly more apoptosis seen after XRT versus after PRT. Although extensive work has been done to identify the mechanisms by which XRT induces cell death, [19] [20] [21] [22] [23] [24] [25] 37, 38 to the best of our knowledge, this is the first report to describe mechanisms of cell death in 4 HNSCC cell lines after a single 4-Gy fraction of PRT versus XRT. Mitotic catastrophe is thought to be the major mechanism of cell death in solid tumors in response to photon radiotherapy. 21, 23 We also found that mitotic catastrophe was the dominant mechanism of cell death in the 2 HPVpositive cell lines and the 2 HPV-negative HNSCC cell lines tested after a single 4-Gy dose of XRT or PRT, and that a single 4-Gy dose of PRT led to higher levels of mitotic catastrophe in HNSCC cells than did XRT. The XRT-induced mitotic catastrophe is thought to be a consequence of radiation-induced DNA damage, or compromised DNA damage repair. [45] [46] [47] [48] We previously used 53BP1 foci as a marker of DNA double-strand breaks and found that a single 4-Gy dose of PRT caused more unrepaired doublestrand breaks at 24 hours than XRT, 36 a finding that could explain the higher rate of mitotic catastrophe in HNSCC cells after PRT versus XRT in the current study. Because targeting DNA damage repair-related proteins, such as Chk1 and Chk2, can promote XRT-induced DNA damage and mitotic catastrophe, 49 our current finding that mitotic catastrophe was more pronounced after PRT than after XRT in the cell lines tested suggests that combining therapy that inhibits DNA damage repair-related proteins may enhance cell death after PRT to a greater extent than after XRT. More interestingly, we observed that mitotic catastrophe after PRT peaked at 48 hours after irradiation in the 2 HPV-negative cell lines and at 72 hours in the FIGURE 2 Senescence in 4 head and neck squamous cell carcinoma cell lines after exposure to photon (X-ray) radiotherapy (XRT) versus proton radiotherapy (PRT) irradiation. Two human papillomavirus (HPV)-negative cell lines (SqCC/Y1 and HN5) and 2 HPV-positive cell lines (UPCI-SCC-154 and UMSCC-47) were exposed to a single 4-Gy dose of XRT or PRT, stained with senescence-associated β-galactosidase (SA-β-gal), and analyzed 4 days and 6 days later. A, Photographs of senescent cells at 6 days after irradiation. Cells were photographed with an optic microscope in at least 10 randomly chosen fields at ×20 magnification. Cells staining positive for SA-β-gal show blue cytoplasmic staining. B, Quantification of senescent cells at 4 days and 6 days after irradiation. Results shown are the means from 3 independent experiments. Both XRT and PRT led to increased senescence relative to control cells in all 4 cell lines (P < .01 for XRT and P < .001 for PRT) at 4 days and 6 days after irradiation, with the percentages higher after PRT than after XRT (P < .01 for all).
Values shown are means ± SEM from at least 3 independent experiments. Student's t tests (unpaired, unequal variance) were used for analysis 2 HPV-positive cell lines studied, perhaps because radiation-induced mitotic catastrophe in solid tumors depends on the proliferation rate and DNA repair capacity of the irradiated cells, 50, 51 and perhaps because DNA damage repair in HPV-negative HNSCC cells is known to be different from that in HPV-positive cells. 52 We speculate that these findings may represent a basis for treatment schedules that involve hypofractionated PRT to treat HNSCC of different HPV status in clinical practice. Cellular senescence is increasingly being recognized as important in photon radiation-induced tumor suppression. 23, 53, 54 The tumor suppressors p53 and p16 are known to have central roles in the accelerated senescence induced by photons. 23, 24 However, because most HPV-negative HNSCC cells do not have wild-type p53, 55 and because HPV-positive HNSCC cells often have P53 degradation and P16 upregulation, 33 it is important to assess potential differences in cellular senescence caused by XRT and PRT. We found in the current study that senescence was a major type of cell death from a 4-Gy dose of PRT or XRT in all 4 of our HNSCC cell lines---2 that were HPVpositive and 2 that were HPV-negative. More importantly, PRT induced more senescent cells than did XRT in all 4 cell lines. Further studies in in vivo systems are warranted to uncover the molecular mechanisms underlying our observations. Senescent cells have a characteristic SA secretory phenotype 56 that can mediate levels of inflammatory cytokines in ways that can activate the innate immune system and thereby lead to tumor suppression. 57 However, emerging evidence that the SA secretory phenotype can promote tumor progression caused by persistent senescent cells [58] [59] [60] suggests that using senolytic compounds, which specifically kill senescent cells, may be an exciting new strategy to enhance tumor suppression. Together with our results that PRT led to more senescence than did XRT in HNSCC cells tested, the role of combination treatment with senolytic compounds and PRT or XRT warrants further investigation. Apoptosis has a modest role in the response of many solid tumors to photon irradiation. For HNSCC cell lines, classical apoptosis is not the predominant mode of radiationinduced cell death. 61, 62 33 Because both PRT and XRT cause DNA damage and because DNA damage is a major pathway by which radiation causes apoptosis, strategies to target apoptosis pathways to enhance PRT-induced or XRT-induced tumor cell apoptosis may be another effective strategy for enhancing the antitumor activity of radiation. Necrosis typically occurs after a large dose of photon radiation 24, 66 but it has also been observed in cancer cell lines and patient tumor tissue-derived cancer cells after a single 4-Gy or 6-Gy dose of photon irradiation. 67 In the current study, compared with the control condition, a single 4-Gy dose of PRT or XRT led to significantly increased necrosis in the HPV-negative SqCC/Y1 cells 48 hours later but no differences were found between PRT versus XRT and no increases in necrosis were found in the other 3 HNSCC cell lines. Mechanistic studies of tumor necrosis have identified several molecular targets that mediate necrosis after treatment [66] [67] [68] ; interfering with those molecular targets to enhance radiation-induced necrotic cell death may be another new approach to enhance radiosensitivity. 66, 67 Our study did have limitations. Our conclusions were based on the responses of 4 human HNSCC cell lines to a single 4-Gy dose of radiation and, hence, may not be generalizable to other HNSCC cell lines or other radiation doses and fractionation schedules or processes within intact organisms subjected to multiple-fraction radiation. Further studies of tumor cell death mechanisms in additional HNSCC cell lines, with additional radiation doses and multiple-fraction PRT and XRT, in vitro and in vivo are warranted. In addition, cell death is a dynamic process, and further investigation using live-cell imaging is needed to determine whether the various cell death mechanisms interact or overlap with each other over time. We are actively exploring the molecular mechanisms of cell death caused by PRT versus XRT with the goal of explaining the greater sensitivity of HNSCC cells to PRT versus XRT and possibly revealing additional potential treatment targets. Moreover, in current clinical practice, the relative biological effectiveness value used to adjust for the physical dose of PRT is assumed to be 1.1. Potential differences in cell death mechanisms under the adjusted physical dose of PRT versus XRT also warrant further investigation.
| CONCLUSION
In conclusion, we present here the first evidence that mitotic catastrophe and senescence are the major types of cell death induced by a single 4-Gy dose of either XRT or PRT in the 4 HNSCC cell lines tested, and that PRT kills more HNSCC cells by either mechanism than does XRT under the current study conditions. These results offer the tantalizing possibility that individual patients with HNSCC may derive different levels of benefit from targeted therapy that interferes with different cell death-related pathways according to whether the radiotherapy is XRT or PRT. Further mechanistic studies are needed to confirm these findings in additional HNSCC cell lines, with other radiation doses, and under in vivo conditions, and to explore potential combination-therapy strategies.
